Author:
Kageji Teruyoshi,Nakagawa Yoshinobu,Kumada Hiroaki
Publisher
Springer Berlin Heidelberg
Reference15 articles.
1. Athanassiou H, Synodinou M, Maragoudakis M et al (2005) Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 23:2372–2377
2. Davis FG, Freels S, Grutsch J et al (1998) Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data. J Neurosurg 88:1973–1991
3. Hatanaka H (1986) Introduction. In: Hatanaka H (ed) Boron neutron capture therapy for tumors. Nishimura, Niigata, pp 1–28
4. Hatanaka H, Kamano S, Amano K et al (1986) Clinical experience of boron-neutron capture therapy for gliomas. A comparison with conventional chemo-immuno-radiotherapy. In: Hatanaka H (ed) Boron neutron capture therapy for tumors. Nishimura, Niigata, pp 349–379
5. Hatanaka H, Nakagawa Y (1994) Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28:1061–1066